Bioventus

Bioventus is a global leader in active healing innovations, focusing on orthobiologics and non-invasive orthopedic solutions. Founded in May 2012 and headquartered in Durham, North Carolina, the company emerged from Smith & Nephew's former Biologics and Clinical Therapies division. Bioventus is supported by investors such as Essex Woodlands and Smith & Nephew. The company offers a range of clinically effective and cost-efficient products, including bone stimulation devices that enhance bone healing and osteoarthritis joint fluid therapies that alleviate pain and improve joint function. Notable products include the EXOGEN bone healing system and joint fluid therapies like SUPARTZ and DUROLANE. Bioventus operates in over 60 countries and emphasizes a customer-led approach, employing over 250 professionals to assist healthcare providers in delivering quality care. Under the leadership of CEO Mark Augusti, Bioventus is dedicated to helping patients regain active lifestyles through high-quality orthopedic diagnostics and therapies.